GE HEALTHCARE TECH.INC. (L0T) - Total Liabilities
Based on the latest financial reports, GE HEALTHCARE TECH.INC. (L0T) has total liabilities worth €26.23 Billion EUR (≈ $30.66 Billion USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore L0T long-term investment intensity to see how much of total assets are deployed in long-term investments.
GE HEALTHCARE TECH.INC. - Total Liabilities Trend (2022–2025)
This chart illustrates how GE HEALTHCARE TECH.INC.'s total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see L0T total assets.
GE HEALTHCARE TECH.INC. Competitors by Total Liabilities
The table below lists competitors of GE HEALTHCARE TECH.INC. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Semiconductor Manufacturing International Corporation
F:MKN2
|
Germany | €17.25 Billion |
|
Brown & Brown Inc
NYSE:BRO
|
USA | $17.28 Billion |
|
Qnity Electronics, Inc
NYSE:Q
|
USA | $6.70 Billion |
|
Moderna Inc
NASDAQ:MRNA
|
USA | $4.20 Billion |
|
Compagnie Generale des Etablissements Michelin SCA
PA:ML
|
France | €16.94 Billion |
|
QBE Insurance Group Limited
AU:QBE
|
Australia | AU$37.51 Billion |
|
KeyCorp
NYSE:KEY
|
USA | $168.68 Billion |
|
Corpay Inc
NYSE:CPAY
|
USA | $22.19 Billion |
Liability Composition Analysis (2022–2025)
This chart breaks down GE HEALTHCARE TECH.INC.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See L0T equity financing ratio to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.22 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.46 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.71 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how GE HEALTHCARE TECH.INC.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for GE HEALTHCARE TECH.INC. (2022–2025)
The table below shows the annual total liabilities of GE HEALTHCARE TECH.INC. from 2022 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | €26.31 Billion ≈ $30.76 Billion |
+7.65% |
| 2024-12-31 | €24.44 Billion ≈ $28.57 Billion |
-2.81% |
| 2023-12-31 | €25.14 Billion ≈ $29.40 Billion |
+40.10% |
| 2022-12-31 | €17.95 Billion ≈ $20.98 Billion |
-- |
About GE HEALTHCARE TECH.INC.
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical… Read more